Markets:

Overview

News

Currencies

International

Treasuries

Stryker Corp (NY:SYK)

330.03 +13.92 (+4.40%)

Streaming Delayed Price Updated: 10:51 AM EDT, Jun 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Can Mid-Cap Lantheus Continue its 2022 Outperformance?

October 28, 2022

Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test.

Via MarketBeat

Topics ETFs Initial Public Offering

3 Medical Stocks On the Rebound ↗

October 26, 2022

As surgeries bounce back toward pre-pandemic levels, these three companies should benefit.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 21, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Stryker to Showcase Innovative Portfolio of Spine Solutions at the North American Spine Society Meeting

October 12, 2022

From Stryker

Via Business Wire

Analyst Ratings for Stryker ↗

September 06, 2022

Within the last quarter, Stryker (NYSE:SYK) has observed the following analyst ratings:

Via Benzinga

Stryker Unveils New Gamma4 Hip Fracture Nailing System ↗

September 01, 2022

Via Benzinga

Where Stryker Stands With Analysts ↗

July 27, 2022

Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022 ↗

October 18, 2022

Upgrades

Via Benzinga

Analyzing Stryker's Short Interest ↗

October 11, 2022

Stryker's (NYSE:SYK) short percent of float has risen 25.0% since its last report. The company recently reported that it has 6.49 million shares sold short, which is 1.85% of all regular shares that...

Via Benzinga

Stryker's Q2 Earnings Miss Street View On Forex & Inflation Pressure ↗

July 27, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 ↗

October 12, 2022

Upgrades

Via Benzinga

Where Stryker Stands With Analysts ↗

October 12, 2022

Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter:

Via Benzinga

Expert Ratings for Stryker ↗

October 12, 2022

Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter:

Via Benzinga

2 Healthcare Stocks That Could Help Make You a Fortune ↗

October 08, 2022

If given enough time, these two stocks can do the heavy lifting in building wealth for you.

Via The Motley Fool

This Savvy Congressman Is Making Trades Under His Kid's Name: Check Out 2 Dividend Stocks He Owns ↗

October 06, 2022

Democratic Congressman Ro Khanna has made more than 13,000 trades in the past three years. The U.S. representative from California is considered one of the most active traders in Congress, according to...

Via Benzinga

Stryker Launches Monterey AL Interbody System with New Pre-clinical Data

October 04, 2022

From Stryker

Via Business Wire

Stryker to host conference call on October 31, 2022

September 29, 2022

From Stryker Corporation

Via GlobeNewswire

Here's How Much You Would Have Made Owning Stryker Stock In The Last 15 Years ↗

September 29, 2022

Stryker (NYSE:SYK) has outperformed the market over the past 15 years by 1.36% on an annualized basis producing an average annual return of 7.12%. Currently, Stryker has a market capitalization of...

Via Benzinga

Stryker Launches Q Guidance System with Spine Guidance Software

September 27, 2022

From Stryker

Via Business Wire

3 Undervalued Dividend Champions With High Return Potential ↗

September 22, 2022

These dividend stocks have potential to generate high returns for income investors. Let's take a closer look at three dividend champions.

Via InvestorPlace

Piper Sandler Maintains Overweight Rating for Stryker: Here's What You Need To Know ↗

September 14, 2022

Piper Sandler has decided to maintain its Overweight rating of Stryker (NYSE:SYK) and raise its price target from $250.00 to $260.00. Shares of Stryker are trading down 0.19% over the last 24 hours, at...

Via Benzinga

Wells Fargo Slashes Price Target On This Stock By Over 71%, Also Check Out Other Major PT Changes Here ↗

September 14, 2022

Wells Fargo cut the price target on Cabaletta Bio, Inc. (NASDAQ: CABA) from $14 to $4. Wells Fargo analyst Derek Archila maintained the stock with an Overweight rating. Cabaletta Bio shares gained 0.9%...

Via Benzinga

Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting

September 14, 2022

From Stryker

Via Business Wire

Disney, GM Got Are CNBC 'Fast Money' Mentions; Jon Najarian Sees Unusual Options Activity In These Stocks ↗

September 09, 2022

CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

Via Benzinga

Stryker Launches New Gamma4 Hip Fracture Nailing System

September 01, 2022

From Stryker

Via Business Wire

Agilent Puts Together Commanding Beat That Ignores Messy Medtech Dynamics ↗

August 17, 2022

Agilent managed to stave off challenges due to Covid and exchange rates for a big beat.

Via Investor's Business Daily

$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,000 Today ↗

August 04, 2022

Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 3.08% on an annualized basis producing an average annual return of 11.07%. Currently, Stryker has a market capitalization of...

Via Benzinga

Stock Market Rally Powers Higher On Fed Rate Hints; Apple, Microsoft, Meta, Amazon, Google Key Earnings: Weekly Review ↗

July 29, 2022

The major indexes made big moves amid key earnings and another big Fed rate hike.

Via Investor's Business Daily

Walmart To $142? Plus This Analyst Raises Price Target On McDonald's ↗

July 27, 2022

Keybanc raised the price target for McDonald's Corporation (NYSE: MCD) from $285 to $290. However, Keybanc analyst Eric Gonzalez maintained the stock with an Overweight rating. McDonald's shares fell...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2022 ↗

July 28, 2022

Via Benzinga

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.